Literature DB >> 23461363

P66Shc-rac1 pathway-mediated ROS production and cell migration is downregulated by ascorbic acid.

Deeba Kirmani1, Hina F Bhat, Muneesa Bashir, Mohammad A Zargar, Firdous A Khanday.   

Abstract

The oxidative role(s) of p66Shc protein has been increasingly expanded over the last decade. However, its relation with the most potent antioxidant molecule, i.e. ascorbic acid has never been studied. We have previously shown that p66Shc mediates rac1 activation, reactive oxygen species (ROS) production and cell death. Here we studied the effect of ascorbic acid on the pathway involving p66Shc and rac1. Our results indicate a decrease in the expression of p66Shc in a dose- and time-dependent manner. We studied the effect of ascorbic acid on rac1 expression and its activity. Ascorbic acid has no effect on total rac1 expression; however, rac1 activation was inhibited in a dose-dependent manner. Results suggest that the decrease in rac1 activity is mediated through ascorbic acid-modulated p66Shc expression. The decrease in rac1 activity was evident in cells transfected with the p66shc mutant (proline motif mutant, at residues P47 to P50). Our studies indicate that p66Shc-mediated ROS upregulation is significantly decreased in the presence of ascorbic acid. Cell migration experiments point towards the inhibition of p66Shc-rac1-mediated migration in the presence of ascorbic acid. Finally, results are suggestive that ascorbic acid-mediated decrease in Shc expression occurs through an increased Shc ubiquitination. Overall, the study brings out the novel role of ascorbic acid in antioxidant signal transduction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23461363     DOI: 10.3109/10799893.2013.770527

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  8 in total

1.  The adaptor proteins p66Shc and Grb2 regulate the activation of the GTPases ARF1 and ARF6 in invasive breast cancer cells.

Authors:  Eric Haines; Caroline Saucier; Audrey Claing
Journal:  J Biol Chem       Date:  2014-01-09       Impact factor: 5.157

2.  p66Shc regulates migration of castration-resistant prostate cancer cells.

Authors:  Matthew A Ingersoll; Yu-Wei Chou; Jamie S Lin; Ta-Chun Yuan; Dannah R Miller; Yan Xie; Yaping Tu; Rebecca E Oberley-Deegan; Surinder K Batra; Ming-Fong Lin
Journal:  Cell Signal       Date:  2018-02-17       Impact factor: 4.315

3.  Vitamin C and E supplementation alters protein signalling after a strength training session, but not muscle growth during 10 weeks of training.

Authors:  G Paulsen; H Hamarsland; K T Cumming; R E Johansen; J J Hulmi; E Børsheim; H Wiig; I Garthe; T Raastad
Journal:  J Physiol       Date:  2014-11-10       Impact factor: 5.182

Review 4.  New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseases.

Authors:  Fabio Di Lisa; Marco Giorgio; Peter Ferdinandy; Rainer Schulz
Journal:  Br J Pharmacol       Date:  2016-04-14       Impact factor: 8.739

5.  Adaptor Protein p66Shc: A Link Between Cytosolic and Mitochondrial Dysfunction in the Development of Diabetic Retinopathy.

Authors:  Manish Mishra; Arul J Duraisamy; Sudarshan Bhattacharjee; Renu A Kowluru
Journal:  Antioxid Redox Signal       Date:  2018-10-03       Impact factor: 8.401

6.  Recombinant adenovirus of human p66Shc inhibits MCF-7 cell proliferation.

Authors:  Xiaoshan Yang; Rong Xu; Yajun Lin; Yongzhan Zhen; Jie Wei; Gang Hu; Hongfan Sun
Journal:  Sci Rep       Date:  2016-08-17       Impact factor: 4.379

7.  Epigenetic memory of oxidative stress: does nephrilin exert its protective effects via Rac1?

Authors:  Desmond D Mascarenhas; David N Herndon; Istvan Arany
Journal:  Biologics       Date:  2017-07-17

8.  Actin Modulation Regulates the Alpha-1-Syntrophin/p66Shc Mediated Redox Signaling Contributing to the RhoA GTPase Protein Activation in Breast Cancer Cells.

Authors:  Roshia Ali; Hilal Ahmad Mir; Rabia Hamid; Basharat Bhat; Riaz A Shah; Firdous A Khanday; Sahar Saleem Bhat
Journal:  Front Oncol       Date:  2022-02-21       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.